Revelation Biosciences, Inc. (REVB) — 分析师展望 / 分析师共识目标价为. 基于 2 位分析师评级, 共识为 看涨 — 2 买入.
分析师预估 每股收益(EPS)为 $-1,436.16 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-9.44 vs 预期 $-1,436.16 (超预期 +99.3%). 2025: 实际 $-23.95 vs 预期 $-36.60 (超预期 +34.6%). 分析师准确度: 0%.
REVB 分析师评级
Buy
基于过去3个月内 2 位分析师对 Revelation Biosciences, Inc. 的评级
EPS 预测 — REVB
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$9.44
vs Est –$1,436.16
▲ 15,113.6% off
2025
Actual –$23.95
vs Est –$36.60
▲ 52.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — REVB
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
